493 Prognostic factors to predict outcomes in patients with HER2-overexpressing metastatic breast cancer treated with trastuzumab containing chemotherapy as first or second line therapy: prognosis grouping according to the prognostic factors
M.J. Park, J.H. Park, Y.H. Park, Y.H. Im, J.S. AhnVolume:
8
Year:
2010
Language:
english
DOI:
10.1016/s1359-6349(10)70514-0
File:
PDF, 64 KB
english, 2010